The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

SLC22A9  -  solute carrier family 22 (organic anion...

Homo sapiens

Synonyms: FLJ23666, HOAT4, OAT4, OAT7, Organic anion transporter 7, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of SLC22A9

  • Thus, hOAT4 is the long-postulated, low-affinity apical urate anion exchanger that facilitates HCTZ-associated hyperuricemia [1].
 

High impact information on SLC22A9

  • Human renal organic anion transporter 4 operates as an asymmetric urate transporter [1].
  • PAH and glutarate are not taken up by HEK293-hOAT4 cells, but they trans-stimulated 6-CF and [(3)H]ES uptake, indicating an asymmetric interaction of hOAT4 with these substrates [1].
  • Moreover, an acidification of the uptake medium increased 6-CF as well as [(3)H]ES uptake, which was reduced by nigericin, suggesting that hOAT4 also can operate as an OA/OH(-) exchanger. hOAT4 facilitates substantial uptake of [(14)C]urate, which was elevated 2.6-fold by intracellular HCTZ [1].
  • Our results indicate that uptake of steroid sulfates by isolated MT is mediated by OATP-B and OAT-4 and suggest a physiological role of both carrier proteins in placental uptake of fetal-derived steroid sulfates [2].
  • Immunohistochemistry of first- and third-trimester placenta detected OAT-4 on cytotrophoblast membranes and at the basal surface of the syncytiotrophoblast [2].
 

Biological context of SLC22A9

  • However, the substrate specificity of OAT4 remains to be investigated in detail [3].
  • CONCLUSIONS: Genetic variation in the gene encoding the luminally expressed OAT4 rather than in the basolaterally expressed OATs may affect the renal clearance of torsemide [4].
 

Anatomical context of SLC22A9

  • Finally, Caco-2 cells were shown to express organic anion transporter 4 (OAT4) mRNA, as was the human large intestine [5].
  • The uptake of oxypurinol by another organic anion transporter (OAT), OAT4 (SLC22A11), which is also expressed at the apical membrane of proximal tubular epithelial cells, was negligible, whereas the uptake of [3H]estrone-3-sulfate by OAT4 was significantly inhibited by oxypurinol [6].
 

Associations of SLC22A9 with chemical compounds

  • HEK-OAT4 cells exhibited concentration-dependent uptake of estrone-3-sulfate, with a K(m) value of 20.9+/-3.53 muM [3].
  • Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4 [3].
  • Although pranlukast is devoid of anionic motifs other than the tetrazole group, it potently inhibited the OAT4-mediated uptake of estrone-3-sulfate, indicating that a tetrazole group may be one important structural feature in substrate recognition by OAT4 [3].
  • We also searched for the potential inhibitors of OAT4 and identified candesartan, candesartan cilexetil, losartan, losartan carboxyl (EXP3174) and valsartan as inhibitors of OAT4, with K(i) values of 88.9, 135.2, 24.8, 13.8 and 19.6 muM, respectively [3].

References

  1. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. Hagos, Y., Stein, D., Ugele, B., Burckhardt, G., Bahn, A. J. Am. Soc. Nephrol. (2007) [Pubmed]
  2. Characterization and identification of steroid sulfate transporters of human placenta. Ugele, B., St-Pierre, M.V., Pihusch, M., Bahn, A., Hantschmann, P. Am. J. Physiol. Endocrinol. Metab. (2003) [Pubmed]
  3. Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. Yamashita, F., Ohtani, H., Koyabu, N., Ushigome, F., Satoh, H., Murakami, H., Uchiumi, T., Nakamura, T., Kuwano, M., Tsujimoto, M., Sawada, Y. J. Pharm. Pharmacol. (2006) [Pubmed]
  4. Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters. Vormfelde, S.V., Schirmer, M., Hagos, Y., Toliat, M.R., Engelhardt, S., Meineke, I., Burckhardt, G., Nürnberg, P., Brockmöller, J. British journal of clinical pharmacology. (2006) [Pubmed]
  5. Site-specific accumulation of the cancer preventive dietary polyphenol ellagic acid in epithelial cells of the aerodigestive tract. Whitley, A.C., Sweet, D.H., Walle, T. J. Pharm. Pharmacol. (2006) [Pubmed]
  6. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Iwanaga, T., Kobayashi, D., Hirayama, M., Maeda, T., Tamai, I. Drug Metab. Dispos. (2005) [Pubmed]
 
WikiGenes - Universities